. (1995). A simple mathematical-model and alternative paradigm for certain chemotherapeutic regimens. Mathematical and Computer Modelling, 22(8), 49-60. doi:10.1016/0895-7177(95)00154-t Pergamon Mats. ~omp~t. ~~e~~~~~ Vol. 22, No. 8, pp. 49-60, 1995 Copyri~ht~lQQ5 Elsevier Science Ltd 
INTRODUCTION
In a recent paper [2] , Panetta and Adam analyzed a two-compartment model of cell-specific chemotherapy (see Figure 1 ). The two compartments represent cycling cells (containing the G1, S, G2, and M phases) and resting cells, respectively. While obviously a simplistic model of the cell cycle (or, equivalently, a simplistic model of the effects of chemotherapy), the mathematical aspects of the model can be investigated in considerable detail, which we set out below. For further details of the chemotherapeutic treatment, the reader is referred to [2] .
The governing system of differential equations is where x = (~1, ~2)'; x1 and 22 represent the cycling and resting (or noncycling) tumor cell mass, respectively. The quantity a is the rate at which cycling cells leave the cycling compartment (including natural decay or death) minis the cycling cell growth rate, b is the rate at which resting cells enter the cycling compartment, and p is the rate at which cycling cells enter the The terms a, b, and /L are exit/entry rates defined in the introduction.
resting compartment.
All the quantities (a,&, and p> are nonnegative. The function g(t) is continuous in any inter& (7~7, (n + 1)~)~ and describes the effects of ~emotherapy on the cycling tumor cells. In the first period, it is defined by g(t) = he-"', 0<t17, (2) where h is the so-called cell-kill parameter, a the drug decay or evacuation rate, 7 is the minimal period of the function g(t), and n + 1 is the period number, n = 0, 1,2. . . .
SCHRijDINGER EQUATION FORM FOR (1)
From equation (l), the following homogeneous second-order differential equation may be derived for zl(t): d2xl dt2 + G1(t)% + G2(+1 = 0,
in general for nr < t I (n + l)~, where
Gl(t) = a + b + g(t),

Gz(t) = g'(t) + b(a -p) + bg(t).
(4 
Equation (3) may be cast into a variety of forms; in particular, Whittaker's differential equation, which is closely related to the canonical form of the confluent hypergeometric differential equation (see Section 3). For the moment., however, we content ourselves with a reformulation of the equation into linear Schrijdinger form. Upon substituting form (2) for g(t) into equations (3) and (4), we obtain, under the change of dependent variable ~(4 = xl(t) exp {+(o~} (6) the equation
C&(t) -;G;(t) -;G;(t)
or after some rearrangement
We note the formal similarity between equation (8) 
wherein i = K is an "energy" associated with a quantum mechanical "particle" in a potential well, V(t), in time, where
The application of "boundary conditions" in time enable us, in principle, to identify the parameter i (which depends only on the details of the cell ~omp~tment entry and exit rates) as an eigenvalue, but let us note first some general features of the time-potential (11) . V(t) is in the form of a Morse-type potential for a molecule (see f3] for details), and as defined here, possesses the following properties:
6)
(ii)
limt+W V(t) = O-, (though, of course, the potential on (0,~) will be periodically translated). Figure 2 .
V(t) is sketched in
y*-L Figure 2 . The Morse-type potential V(t) = y2evzat -.fkTat (see equation (9)) arising from the equation (2) for g(t). This potentiaI on (0,~) is periodically repeated in time.
ANALYTIC SOLUTIONS
In (8)) we define a new independent variable T = ?e-at (Y '
and a new dependent variable F(T) = T--P/ae0/2)TY,
FOR (8)
(12)
where K = -p2 (K < 0 for the choice of parameters used later in Section 5) and 1 = L/2cry.
Then, (8) becomes
which is Kummer's canonical form for the confluent hypergeometric equation in which we make the following identifications:
(Y ' so ii = (E/2) -1. Provided E is not an integer [4] , there are two linearly independent solutions to (14), namely 1J'r (6, z; T) and T1-"1Fl(6 -E + 1,2 -2;; T), using the standard notation for confluent hypergeometric functions. In terms of y(T(t)), the general solution of (8) is
where we have now dropped the "iFi" notation for simplicity. In terms of the original variables, from (6), (12) , and (16) z,(t) = ,-(1/2)(a+b)t,(h12cr)e-at~(~).
Prom (16), therefore, assimilating constants into A and B, we have two linearly independent solutions (if E is neither zero nor an integer) yi(t) = e -Pte-(VaFat~ (a, 2;; se-at) , (14), we define
then it can be shown after some algebra that W satisfies Whittaker's differential equation, which has the advantage of being self-adjoint
where m2 = p2/cx =. If 2m is not an integer, two linearly independent solutions of (21) are 
THE CHEMOTHERAPEUTIC REGIMENS AS A PERIODIC POTENTIAL
If the potential V(t) is periodic with minimal period 7, i.e.,
then the Schrodinger equation (10) is invariant with respect to all translations by integer multiples of T, t + t -t TV. If yl(t) and y=(t) are two linearly independent solutions of (lo), then, in particular so are yl(t + T) and yz(t + T); indeed, these latter two solutions can be written as linear combinations of the former two. From within the solution space spanned by yi and ~2, Floquet theory assures us that there are two solutions, Yl(t) and Y=(t) say, with the property that
where each Xi is a constant. It naturally follows that
denote the Wronskian determinant. From (25), it follows that
By a well-known theorem [4] , the Wronskian for solutions of (10) 
At this point in the quantum mechanical literature (see e.g., [3] ), it is demonstrated, using (26) and the concept of an "infinite crystal," that Xi and X2 are complex numbers with modulus unity (Bloch's theorem).
However, the independent variable here is time, and the treatment is finite in duration (see comments in [5] ), so we are not thus restricted. An obvious constraint is that we discard that solution y2 (say) for which X2 > 1, and retain yi for which Xi < 1. This is merely the constraint noted in Section 3 (equation (23)). It is a straightforward matter to examine (in principle, at least) what implicit constraints there may be on other parameters within the model. We will now drop the subscript "1" on Yi(t) and Xi and write the former as a linear combination of yi and ~7.. Thus,
O<t<T.
(30)
In the next period, r I x < 27, on using (25)
Y(t) = X[Ay$ -T)+ Byz(t -T)]. (31)
By requiring that Y(t) and Y'(t) must be continuous at t = 7, the condition for nontrivial A and B is the standard one, namely
where W(0) and W(r) refer to the Wronskians of yr and Ys evaluated at t = 0 and t = 7, respectively; J(0, r) is defined by
Note that W(0) = W(T) = W. In solving (33) for A, we will retain the root X such that 0 < ReX 5 1.
Those parameter values such that ReX falls outside the interval [O,l] will be deemed as corresponding to an "ineffective" regimen. Let us decompose the solutions of (33) in an obvious manner from
Both roots will be real if J2 2 4W2; both will be negative or positive if in addition, J and W have the same or opposite signs, respectively. The roots will be complex conjugates if J2 < 4W2; in addition, ReX will be negative or positive if J and W have the same or opposite signs accordingly. Since j J/ZWl < 1 automatically, one root will have 0 < ReX < 1 whenever J/W < 0. Regardless of whether X is real or complex, an optimal restriction may be obtained by considering X = eie (where 0 is a real number which may depend on the model parameters), since for X = Reie, (R > 1), one root will be such that j X I= R and the other (of interest here) will be such that 1 X I= R-l < 1. Thus, from (35), it follows that
Now if the model parameters were such that I& 1 > 1, it would be clear that (36) could not be satisfied. This is the mathematical basis for the existence of "forbidden energy bands" in solid state physics, and to this end, we examine (33) further by digressing briefly to the physical motivating example of electrons in a periodic square lattice [3, 6, 7] .
THE "EIGENVALUE" i
From equation (9), we have noted that
It is clear that i < 0, for we may rewrite this ss
for a, b,p all positive, justifying the choice of K = -p2 in equation (13).
In the qu~tum mech~ica1 problem for a potential well, such negative eigenvalues correspond to "bound states" of the system. We may also carry over some of the terminology to advantage in the present model. For the Morse potential V(t) described by equation (ll), the minimum occurs at t = t, = cr -r In (2r2fL), with value V(t,) = -L2/4y2 (see Figure 3) . A bound state will be said to occur if i E f-I V(k*) I,% @9)
i.e., if which places restrictions on the parameter set {a, b, p, cr}-notice this is independent of the dosage h-in p~ticul~r on (Y, if the remainder is prescribed, i.e., either
-(a c b).
(42)
Note also that V(~) is positive or negative according to whether y2 -L is positive or negative, i.e., when h is greater than or less than the quantity 4 -2(ty i a + b),
respectively. The minimum of V(t) is actually attained if 7 2 t,.
V(O For the problem at hand (see Figure 3 ), E < 0 and VI + -VO, so we substitute E = kf = -Kf, K1 > 0 into (44), noting that Kz is now -Vo+Kf < 0, so Kij = -kg < 0 for -VO < E < 0.
Under these circumstances, a new form of (44) 
Since the first term on the left exceeds one for nonzero parameters, and the second term is positive, this criterion is never satisfied for real parameters and R 5 1.
The reason for the existence of forbidden bands in the quantum-mechanical context (which is a boundary value problem for y(z)) is that the waves, in traversing the potential V(z) are reflected in phase by the potential and so interfere destructively with an "incoming" wave so that it is effectively annihilated. In the present context, it appears that the "feedback" from the chemotherapy for some ranges of dosage, period and all exit/entry rates is very counterproductive to the succeeding segment of the regimen. 
for 0 < IC < 1 (the limits exist as z approaches O+ and l-, respectively). If we were investigating a potential barrier rather than a well, the appropriate domain would be z E (0,l) U(l) CXJ) (so written because of two different expressions which occur if E > VO and E < Vo). It can be seen from Figure 4 that f(z) > 1 (the "forbidden" region) when z exceeds about 0.57, i.e., for the parameters chosen here, fi should be at most 57% of the "depth of the well in Figure 3 ." 
PIECEWISEUNIFORM g(t)
If instead of the form (2), we choose a box-type function for g(t), namely
then the periodic potential in the Schrijdinger equation is correspondingIy different. Indeed, in the sense of generalized functions, g'(t) = -hS(t -T) (see Figure 5) , so that from (7) Gz(t) -;G:(t) -;G:(f) = 6(o -cl)-+ bg + $ -&zfb+g)"
T<t<T. As in Section 2, we identify the terms in the Schrodinger equation (10) a in which case VO is the well depth) and width T with a delta function "spike" of strength h/2 at t = T (see Figure 5) . Rather than analyse this model in detail at this point, we merely decompose this problem into two subproblems, each of which represents an extreme: (i) box function potential only, and (ii) delta function potential only.
(i) Box Function Potential
This case is easily dealt with if Vi > 0 (i.e., a barrier) because A = E < 0 reduces the problem to one previously discussed in Section 5. The relation (44) is neuer satisfied. In quantum mechanical terms, all energies are forbidden; in ~emotherapeutic terms (according to this model) no regimen works. If VO < 0 and I.,%'[ < IVol, then the situation reduces to that defined by equation (45), namely there exists some range of E for which the regimen will not work effectively.
(ii) Delta-function Potential (Shifted to t = T)
The analysis for this situation is less algebraically intensive than for a piecewise-continuous function. In the quantum theoretical literature, a periodic potential of this type is referred to as a "Dirac comb" [3, 8] .
F'rom (30) and (311, we obtain, for the equation 
AeKT + Be-KT = X(A + B), XK(A -B) -K (AeK" -BemK7) = f (AeKT + Be-"').
It is easily shown, directly or using (33), that
(531 
we take the smallest real root x = Tj -(q2 -1)(1'2) 5 1,
This X is a monotone function of q, decreasing from one as q increases. Since a general requirement for effective chemotherapy is that X is as small as possible, this corresponds to making q as large as practical constraints on the parameters will permit. (Note that (62) is valid for all 7) 2 '1, in contrast to subproblem (i) which is never satisfied for Vs > 0.) This can be accomplished for given r by increasing K = [bh -t-(1/4)(a -b)2](1'2); in particular, increasing a and b by the same amount would increase K and leave Vo (assumed small here to suppress the box function contributions) unchanged. Changing a, b, and ~1 may be possible in real terms through the use of growth factors (see the discussion in Section 7). Another choice, apparently, to decrease X is to increase the period r for given K. This permits more resting cells to move to the cycling comp~tment, and thus, be exposed to the ~emotherapeutic regimen, but the submodel is not sophisticated enough to incorporate an implicit restriction on the optimal value of r (clearly r -+ 00 is inappropriate!).
What may we infer, in the light of these two submodels, about the full box/delta function potential? Recalling that the first submodel implies no regimen is valid, and the second implies that all regimens are valid (though differing in efficacy), it seems reasonable to suggest that the full potential may exhibit regimes of validity, as does the more realistic potential based on exponential decay discussed in Section 2.
DISCUSSION
59
In this article, we have identified (via several variable rearrangements) a system of ordinary differential equations arising in a model of cell-specific chemotherapy, with the linear Schrodinger equation of quantum mechanics. However, the independent variable in this equation is time, for obvious reasons. Furthermore, reflecting the fact that the chemotherapeutic regimen is periodically administered leads to the consideration of a periodic potential V(t). Much work has been carried out for periodic spatial potentials V(x) (in solid state physics, for example), and some of this material has been adapted for use in the present context. Specifically, the exponentially decreasing function g(t) describing the effect of chemotherapy on cycling tumor cells in one period gives rise to a Morse-type potential, well known in the quantum mechanical literature (see [3] for further references). Solutions to the governing equation can be given in terms of confluent hypergeometric functions (equations (18) and (19)) or Whittaker functions (equations (22)). By regarding the potential V(t) as periodic, we are led in a standard fashion to examine so-calied characteristic multipliers X,, i = I,2 (defined by equation (25)).
In a spatial boundary-value problem, these Xi are sometimes referred to as eigenvalues, but we retain that term for the parameter i which appears in the Schrodinger equation (10) . Constraints exist for these multipliers
Xi (see equations (33), (35), for example); there is an obvious biological requirement that the appropriate Xi has modulus less than one (so that the cell population will decrease after each treatment).
The constraints discussed in Section 4 are completely general, and utilize any appropriate pair of linearly independent solutions of the Schrodinger equation.
Thus, the sets (18), (19), and (22) are both ca.ndidates for detailed examination of parameter space. This is not carried out in the present article because only limited information is available on the parameters (see [2, 9] and below.). Instead, we choose to illustrate here the fundanlental implications of the model by fitting a "rectangular well" to the Morse potential V(t) (see Figure 3 ). This has the decided advantage that the constraints on the multipliers Xi can be obtained with relative ease. (For a very different application of potential wells and barriers, see [lo] ). It is shown in Section 5 that the "eigenvalue" i is always negative for the model (11, and that the governing constraint equation for the rectangular well is equation (45). This equation cannot be satisfied for some ranges of i (or energy E in quantum mechanical terminology). Figure 4 illustrates a specific example of this feature. In the literature of solid state physics, such regions of X-space are referred to as forbidden bands, and arise physically because of coherent reflections of "waves" from the potential that destructively interfere with those "'waves." In the present context, an appropriate interpretation appears to be that for certain choices of the cell exit/entry rates a, b, a~nd p (and hence A, via (37)) the chosen dosage and period are such that some type of negative feedback arises between a given period of administration and the subsequent one. As mentioned above, the information on a, b, and 1-1 is sparse Birkhead et al. [9] give a set of parameter values from breast cancer data. For this model. the set corresponds to and therefore ineffective regimen. Note that while i depends only on the set {a, b, p}, to = LY-' in (r2/L) and Vb = L2/4y2, both depend on the set {a, h, a, h). Thus, in principle, the "external" variables o, h, and r may be varied easily to place i in a chemotherapeutically acceptable region such that equation (45) (or its analogue for the Morse potential in terms of confluent hypergeometric or Whittaker functions) is satisfied. However, there is another intriguing possibility regarding the "internal" variables a, b, and p. Growth factors increasingly are being used to help make chemotherapeutic drugs more effective. Growth factors (or inhibitors) are hormones that can stimulate (or inhibit) the normal cellular proliferation processes. Further information may be found in [11,1' 2) (and also [2] for specifically chemotherapeutic applications). They can be used to modify the entry/exit rates from one cell compartment to another in order to optimize the cell kill rate. This corresponds to varying the "eigenvalue" A, and again could be used to place the regimen (i.e., the full set {a, h, ~,a,b,p)) in an acceptable region of parameter space. Conversely, the use of growth factors to enhance or optimize the cell kill rate may on occasion render the chemotherapy ineffective by modifying some parameters in such a way that equation (45) or its more realistic analogue may no longer be satisfied. In Section 6, a still simpler form of g(t) is investigated. Thii does not provide as rich a structure as the exponential decay model, as might be expected, but it does contain a feature that may be expected to be present in more general models of the type discussed in this paper, especially if a discontinuity in g(t) occurs for t E (0,~); i.e., in the fundamental domain. The two submodels considered represent extremes in the sense that any more realistic model (such as that considered in the main body of this paper, based on equation (2)) can be expected to exhibit a wide range of behavior, in that some regimens (or parameter sets) are effective (i.e., "allowed" by the system) and others are not. This is indeed the case for the exponential decay model discussed here. Having established the possibility of such a paradigm, or way of viewing the periodic administration of drugs to destroy tumor cells, it will be of great interest to examine more detailed models and their domains of parameter validity as more experimental and clinical information becomes available. This may eventually provide a rational basis for the "trial and error" method so clearly described by Skipper [l] :
Over 20 years of experimental and clinical experience has demonstrated that intuitive or trial-and-error manipulations of doses, schedules, and combination of drugs-without guidance as to the effects of each manipulation-are apt to provide little or no improvement in combination chemotherapy designs.
